Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease

Molecular and Cellular Biochemistry

Volumn 357, Issue 1-2, 2011, Pages 171-179

  Calderon Salinas J V ^c   Munoz Reyes E G ^a   Guerrero Romero, J F ^b   Rodriguez Moran M ^b   Bracho Riquelme, R L ^a   Carrera Gracia, M A ^a   Quintanar Escorza, M A ^a  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Diabetes; Eryptosis; Kidney diseases; Oxidative stress; Phosphatidylserine (PS)

Indexed keywords

ANNEXIN; PHOSPHATIDYLSERINE; ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CELL DEATH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE DURATION; ERYPTOSIS; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSMOTIC STRESS; OXIDATIVE STRESS; PROTEIN BINDING; APOPTOSIS; BLOOD; CHRONIC KIDNEY FAILURE; DISEASE COURSE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ADULT; ANNEXINS; ANTIOXIDANTS; APOPTOSIS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHATIDYLSERINES; SUPEROXIDE DISMUTASE;

EID: 84857435212     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0887-1     Document Type: Article

References (36)

1. IDF (2009) Diabetes Atlas at the 20th World Diabetes Congress in October 2009, Montreal, Canada. http://www.diabetesatlas.org/. Accessed February, 2011
2. Golbidi S, Ebadi SA, Laher I (2011) Antioxidants in the treatment of diabetes. Curr Diabetes Rev 7(2):106-125
3. American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care, http://care.diabetesjournals.org/content/30/ suppl-1/S42.full. Accessed February, 2011
4. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA (2010) Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm 2010:453892
5. Takayanagi R, Inoguchi T, Ohnaka K (2011) Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus. J Clin Biochem Nutr 48(1):72-77
6. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C (2010) Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai 93(6):682-693
7. Mahboob M, Rahman MF, Grover P (2005) Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singap Med J 46(7):322-324 (Pubitemid 40992146)
8. Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N, Ramesh B, Baharani A, Shah K, Kamireddy SC, Priyatham G, Balakumaran TA, Balakumaran SS, Kamath A, Rao A (2009) Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 12(2):121-127
9. Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38(12):1539-1543 (Pubitemid 20006678)
10. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058-1070
11. Singh DK, Winocour P, Farrington K (2011) Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7(3):176-184
12. Lam CS, Benzie IF, Choi SW, Chan LY, Yeung VT, Woo GC (2011) Relationships among diabetic retinopathy, antioxidants, and glycemic control. Optom Vis Sci 88(2):251-256
13. Tsutsui H, Kinugawa S, Matsushima S, Yokota T (2011) Oxidative stress in cardiac and skeletal muscle dysfunction associated with diabetes mellitus. J Clin Biochem Nutr 48(1):68-71
14. Wagener FAD, Dekker D, Berde JH, Sharstuhl A, Van der Vlag J (2009) The role of reactive oxygen species in apoptosis in the diabetic kidney. Apoptosis 14:1451-1458
15. Shah SV, Baliga R, Rajapurka M, Fonseca VA (2007) Oxidants in chronic kidney disease. J Am Soc Nephrol 18:16-28 (Pubitemid 46053418)
16. Puchades Montesa MJ, González Rico MA, Solís Salguero MA, Torregrosa Maicas I, Tormos Muñoz MC, Saez Tormo G, Juan Garcia I, Miguel Carrasco A (2009) Study of oxidative stress in advanced kidney disease. Nefrologia 29(5):464-473
17. Hur J, Sullivan KA, Schuyler AD, Hong Y, Pande M, States DJ, Jagadish HV, Feldman EL (2010) Literature-based discovery of diabetes- and ROS-related targets. BMC Med Genomics 3:49
18. Zitouni K, Nourooz-Zadeh J, Harry D, Kerry SM, Betteridge DJ, Cappuccio FP, Earle KA (2005) Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy. Diabetes Care 28(7):1698-1703 (Pubitemid 40923080)
19. Beisswenger PJ, Drummond KS, Nelson RG, Howell SK, Szwergold BS, Mauer M (2005) Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 54(11):3274-3281 (Pubitemid 43334385)
20. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G Jr, Thornalley PJ, Schleicher E, Wieder T, Lang F (2006) Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 18(4-5):223-232 (Pubitemid 44946977)
21. Pavone B, Bucci S, Sirolli V, Merlini G, Del Boccio P, Di Rienzo M, Felaco P, Amoroso L, Sacchetta P, Di Ilio C, Federici G, Urbani A, Bonomini M (2011) Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. Mol Biosyst 7(3):651-658
22. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A (1999) Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 10(9):1982-1990 (Pubitemid 29402520)
23. KDOQI (2007) Diabetes and chronic kidney disease. Guidelines. Guidelines for CKD Care. http://www.kidney.org/professionals/kdoqi/guideline-diabetes/ guide2.htm. Accessed February, 2011
24. Kambayashi Y, Binh NT, Asakura HW, Hibino Y, Hitomi Y, Nakamura H, Ogino K (2009) Efficient assay for total antioxidant capacity in human plasma using a 96-well microplate. J Clin Biochem Nutr 44(1):46-51
25. 2+]i concentration in human erythrocytes incubated with lead. Toxicol In Vitro 24(5):1338-1346
26. Tait JF, Gibson D (1992) Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 298:187-191
27. Reynoso R, Salgado LM, Calderón V (2003) High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Mol Cell Biochem 46(1-2):155-162 (Pubitemid 36798736)
28. Arreola-Mendoza L, Del Razo LM, Mendoza-Garrido ME, Martin D, Namorado MC, Calderon-Salinas JV, Reyes JL (2009) The protective effect of alpha-tocopherol against dichromate-induced renal tight junction damage is mediated via ERK1/2. Toxicol Lett 191(2-3):279-288
29. Cervantes-Cervantes MP, Calderon-Salinas JV, Albores A, Muñoz-Sanchez JL (2005) Cooper increases the damage to DNA and proteins caused by reactive oxygen species. Biol Trace Elem Res 103(3):229-248 (Pubitemid 40628898)
30. 2 in the regulation of programmed erythrocyte death. Cell Death Differ 12:415-428 (Pubitemid 40662840)
31. Lang F, Gulbins E, Lang PA, Zappulla D, Föller M (2010) Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 26(1):21-28
32. Banerjee T, Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124(3):391-402 (Pubitemid 38167992)
33. Solá E, Vayá A, Martínez M, Moscardó A, Corella D, Santaolaria ML, España F, Hernández-Mijares A (2009) Erythrocyte membrane phosphatidylserine exposure in obesity. Obesity 17(2):318-322
34. Föller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F (2009) Suicide for survival death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 24(3-4):133-140
35. Festa A, D'Agonstino R, Howard G, Mykkanen L, Tracy R, Haffner S (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703-1710
36. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F (2005) Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 15(5):195-202 (Pubitemid 40868969)